Hyun-Tak Jin
Chief Tech/Sci/R&D Officer at PROGEN CO., LTD.
Net worth: 527 259 $ as of 2024-05-30
Network origin in Hyun-Tak Jin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hyun-Tak Jin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Michigan State University | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| YUNGJIN PHARM. CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| PANSTAR ENTERPRISE CO.,LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
| DAEHAN STEEL CO., LTD. | Steel | Corporate Officer/Principal | |
| Seoul National University | College/University | Undergraduate Degree | |
| PT KALBE FARMA TBK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Hanyang University | College/University | Corporate Officer/Principal | |
| Ewha Womans University | College/University | Corporate Officer/Principal | |
| Sungkyunkwan University | College/University | Corporate Officer/Principal | |
| University of Indonesia | College/University | Undergraduate Degree | |
| GENEXINE, INC. | Biotechnology | Director/Board Member | |
PT Sanghiang Perkasa
 PT Sanghiang Perkasa Pharmaceuticals: OtherHealth Technology Part of PT Kalbe Farma Tbk, PT Sanghiang Perkasa is an Indonesian company that manufactures and markets nutritional products. The company is based in Jakarta, Indonesia. | Pharmaceuticals: Other | Chairman | |
PT Dankos Farma
 PT Dankos Farma Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, PT Dankos Farma is an Indonesian pharmaceutical company that manufactures pharmaceutical products. The company is based in Jakarta Timur, Indonesia. Mulialie has been the CEO of the company since 2020. | Pharmaceuticals: Major | Sales & Marketing | |
PT Bifarma Adiluhung
 PT Bifarma Adiluhung Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, PT Bifarma Adiluhung is an Indonesian biotechnology company that provides clinically proven and guaranteed biopharmaceutical generics. The company is based in Jakarta Pusat, Indonesia. The CEO of the company is Sie Djohan. | Pharmaceuticals: Major | Chief Executive Officer | |
Innogene Kalbiotech Pte Ltd.
 Innogene Kalbiotech Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, Innogene Kalbiotech Pte Ltd. is a Singaporean pharmaceutical company that manufactures and wholesales pharmaceutical products. The company is based in Singapore, Singapore. | Pharmaceuticals: Major | Director/Board Member | |
PT Kalbio Global Medika
 PT Kalbio Global Medika BiotechnologyHealth Technology Part of PT Kalbe Farma Tbk, PT Kalbio Global Medika is an Indonesian company that manufactures and markets biologic drugs. The company is based in Bekasi, Indonesia. The CEO of the company is Sie Djohan. | Biotechnology | Chief Executive Officer | |
| PT Kalgen DNA | Chief Executive Officer | ||
PT Innolab Sains Internasional
 PT Innolab Sains Internasional Medical/Nursing ServicesHealth Services PT Innolab Sains Internasional engages in provision of clinical laboratory services. The company was founded in April 2016 and is headquartered in Jakarta, Indonesia. | Medical/Nursing Services | Chairman | |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Chief Executive Officer |
Statistics
International
| Indonesia | 10 |
| South Korea | 9 |
| United States | 3 |
| Singapore | 2 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 8 |
| Producer Manufacturing | 2 |
| Non-Energy Minerals | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 7 |
| Chief Executive Officer | 5 |
| Chairman | 4 |
| Doctorate Degree | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Sie Djohan | 11 |
| Chang-Joon Song | 6 |
| Young-Dae Yoon | 5 |
| Jong-Kyun Kim | 3 |
| Sang-Heon Cho | 1 |
| Ko-Yeon Kim | 1 |
| Jae-Yong Kim | 1 |
- Stock Market
- Insiders
- Hyun-Tak Jin
- Company connections
